Victorian Lung Cancer Service Redesign Project: impacts of a quality improvement collaborative on timeliness and management in lung cancer

被引:4
|
作者
Largey, Geraldine [1 ]
Briggs, Peter [1 ]
Davies, Heather [1 ]
Underhill, Craig [6 ]
Ross, Cara [6 ]
Harvey, Kellie [2 ]
Blum, Robert [7 ]
Parker, Carol [7 ]
Guthrie, Christal [7 ]
Parente, Phillip [3 ]
Trevorah, Brooke [3 ]
Torres, Javier [8 ]
Mott, Carole [8 ]
Lancaster, Cheryl [8 ]
Brand, Margaret [4 ]
Earnest, Arul [4 ]
Pellegrini, Breanna [4 ]
Reed, Marita [5 ]
Zalcberg, John [4 ]
Stirling, Rob [2 ,4 ]
机构
[1] Monash Univ, Southern Melbourne Integrated Canc Serv, Melbourne, Vic, Australia
[2] Monash Univ, Dept Resp Med, Alfred Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Dept Med Oncol, Eastern Hlth, Melbourne, Vic, Australia
[4] Monash Univ, Dept Med, Melbourne, Vic, Australia
[5] Dept Hlth & Human Serv Qual & Canc Outcomes, Melbourne, Vic, Australia
[6] Albury Wodonga Hlth, Dept Border Med Oncol, Wodonga, Australia
[7] Bendigo Hlth Care Grp, Dept Med Oncol, Bendigo, Australia
[8] Goulbourn Valley Hlth, Dept Med Oncol, Shepparton, Vic, Australia
关键词
lung cancer; quality; improvement; collaborative; CARE; DIAGNOSIS; SURVIVAL;
D O I
10.1111/imj.15043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Lung cancer management is characterised by a high disease burden, poor survival and substantial variation in management and outcomes. Service redesign provides opportunities for quality improvement (QI) and this improvement may be leveraged across multiple sites using QI collaboration. Aim This initiative targeted Quality Improvement (QI) in lung cancer management, engaging a QI collaborative using service redesign methodologies in five Victorian hospitals. QI targets included timeliness from referral and diagnosis to treatment, multi-disciplinary meeting (MDM) presentation and supportive care screening. Redesign strategies targeted process sustainability through enhanced team capability. Methods This study engaged a prospective quality improvement cohort design targeting newly diagnosed tissue confirmed lung cancer with 6-month pre-intervention period and 6-month redesign implementation period, between September 2016 and August 2017, evaluated using Interrupted Time Series Analysis. Hospital sites included three regional and two metropolitan hospitals in Victoria. QI redesign targeted time intervals from referral to first specialist appointment (FSA), referral to diagnosis, diagnosis to first treatment (any intent), MDM documented in medical records and Supportive Care Screening Tool documented in medical records. Results There was a marked reduction in referral to FSA interval across all sites, with median (interquartile range) falling from 6 (0-15) to 4 (1-10) days, and proportion seen by a specialist within 14 days increased from 74.3% to 84.2%. The interval between diagnosis and treatment was not substantively changed in the 6-month implementation period. The proportion of subjects with documented presentation to the MDM increased from 61% to 67%. The proportion for which Supportive Care Screening documentation remained low at 26.3% post-intervention. Conclusions Data-driven redesign initiatives enable identification and analysis of clinical practice variation and may be utilised to enhance timeliness of cancer care and improve local data service capabilities.
引用
收藏
页码:2061 / 2068
页数:8
相关论文
共 50 条
  • [41] TIMELINESS OF MANAGEMENT FOR NONSMALL CELL LUNG CANCER PATIENTS IN SOUTH WESTERN SYDNEY
    Chandra, Amrita
    Vinod, Shalini
    Berthelsen, Angela
    Descallar, Joseph
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 110 - 111
  • [42] Concepts for quality assurance in the management of lung cancer
    Blankenburg, Thomas
    Flentje, Michael
    Friedel, Godehard
    Huber, Rudolf M.
    Tesch, Hans
    ONKOLOGIE, 2006, 29 : 20 - 24
  • [43] A multicentre randomised controlled trial of reciprocal lung cancer peer review and supported quality improvement: results from the improving lung cancer outcomes project
    Russell, G. K.
    Jimenez, S.
    Martin, L.
    Stanley, R.
    Peake, M. D.
    Woolhouse, I.
    BRITISH JOURNAL OF CANCER, 2014, 110 (08) : 1936 - 1942
  • [44] A multicentre randomised controlled trial of reciprocal lung cancer peer review and supported quality improvement: results from the improving lung cancer outcomes project
    G K Russell
    S Jimenez
    L Martin
    R Stanley
    M D Peake
    I Woolhouse
    British Journal of Cancer, 2014, 110 : 1936 - 1942
  • [45] The lung cancer framework: Optimising lung cancer service delivery
    Daveson, Barbara
    Milch, Vivienne
    Chynoweth, Jennifer
    Kable, Le-Tisha
    Austen, Melissa
    Basrai, Harleen
    Salvestrin, David
    Wade, Rosemary
    Andereisz, Cleola
    Zorbas, Helen
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 111 - 111
  • [46] IMPROVING THE LUNG CANCER SCREENING RATE IN AN INTERNAL MEDICINE CLINIC: A QUALITY-IMPROVEMENT PROJECT
    Wolfe, Zachary
    Lekkala, Manidhar
    Ghimire, Subhash
    Pamula, John
    ANTICANCER RESEARCH, 2018, 38 (09) : 5557 - 5557
  • [47] Regional process redesign of lung cancer care: a learning health system pilot project
    Fung-Kee-Fung, M.
    Maziak, D. E.
    Pantarotto, J. R.
    Smylie, J.
    Taylor, L.
    Timlin, T.
    Cacciotti, T.
    Villeneuve, P. J.
    Dennie, C.
    Bornais, C.
    Madore, S.
    Aquino, J.
    Wheatley-Price, P.
    Ozer, R. S.
    Stewart, D. J.
    CURRENT ONCOLOGY, 2018, 25 (01) : 59 - 66
  • [48] Timeliness to treatment in patients with lung cancer at UVA Cancer Center.
    Tola, Geda
    Spencer, Hannah E.
    Hall, Richard Delmar
    Horton, Bethany J.
    Gentzler, Ryan D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [49] Lung Cancer Disease Pathway Management Initiative: A Novel Approach to Provincial Quality Improvement
    Ung, Y. C.
    Evans, W. K.
    Assouad, N.
    Sawka, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S542 - S542
  • [50] TIMELINESS IN LUNG CANCER CARE VA CONNECTICUT.
    Hunnibell, Laura
    Onze, Kathy
    Flanagan, Mary
    Connery, Donna
    Rose, Michal
    Hampel, Judith
    Lerz, Kathryn
    ONCOLOGY NURSING FORUM, 2010, 37 (03) : E225 - E225